The Association of Podocin R229Q Polymorphism With Increased Albuminuria or Reduced Estimated GFR in a Large Population-Based Sample of US Adults

American Journal of Kidney Diseases

Volumn 52, Issue 5, 2008, Pages 868-875

  Köttgen, Anna ^a   Hsu, Charles C ^a   Coresh, Josef ^a   Shuldiner, Alan R ^b   Berthier Schaad, Yvette ^a,c   Gambhir, Tejal Rami ^a   Smith, Michael W ^c   Boerwinkle, Eric ^d   Kao, W H Linda ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c SAIC FREDERICK INC   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

albuminuria; association study; functional variant; NPHS2; podocin; population based sample

Indexed keywords

ALBUMIN; CREATININE; PODOCIN;

ADULT; ALBUMINURIA; ALLELE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; UNITED STATES;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALBUMINURIA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; UNITED STATES;

EID: 54149115734     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.02.306     Document Type: Article

References (30)

1. Roselli S., Gribouval O., Boute N., et al. Podocin localizes in the kidney to the slit diaphragm area. Am J Pathol 160 (2002) 131-139
2. Boute N., Gribouval O., Roselli S., et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24 (2000) 349-354
3. Caridi G., Bertelli R., Carrea A., et al. Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J Am Soc Nephrol 12 (2001) 2742-2746
4. Karle S.M., Uetz B., Ronner V., Glaeser L., Hildebrandt F., and Fuchshuber A. Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol 13 (2002) 388-393
5. Tsukaguchi H., Sudhakar A., Le T.C., et al. NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J Clin Invest 110 (2002) 1659-1666
6. Caridi G., Bertelli R., Scolari F., Sanna-Cherchi S., Di Duca M., and Ghiggeri G.M. Podocin mutations in sporadic focal-segmental glomerulosclerosis occurring in adulthood. Kidney Int 64 (2003) 365
7. Caridi G., Bertelli R., Di Duca M., et al. Broadening the spectrum of diseases related to podocin mutations. J Am Soc Nephrol 14 (2003) 1278-1286
8. Weber S., Gribouval O., Esquivel E.L., et al. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int 66 (2004) 571-579
9. Dusel J.A., Burdon K.P., Hicks P.J., Hawkins G.A., Bowden D.W., and Freedman B.I. Identification of podocin (NPHS2) gene mutations in African Americans with nondiabetic end-stage renal disease. Kidney Int 68 (2005) 256-262
10. Franceschini N., North K.E., Kopp J.B., McKenzie L., and Winkler C. NPHS2 gene, nephrotic syndrome and focal segmental glomerulosclerosis: A huge review. Genet Med 8 (2006) 63-75
11. Zhang S.Y., Marlier A., Gribouval O., et al. In vivo expression of podocyte slit diaphragm-associated proteins in nephrotic patients with NPHS2 mutation. Kidney Int 66 (2004) 945-954
12. ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: Design and objectives. Am J Epidemiol 129 (1989) 687-702
13. National Heart, Lung and Blood Institute: Atherosclerosis Risk in Communities (ARIC) Study. Operations Manual 7: Blood Collecting and Processing (1988), National Heart, Lung and Blood Institute, Bethesda, MD
14. National Heart, Lung and Blood Institute: Atherosclerosis Risk in Communities (ARIC) Study. Operations Manual 8: Lipid and Lipoprotein Determinations (1987), National Heart, Lung and Blood Institute, Bethesda, MD
15. National Heart, Lung and Blood Institute: Atherosclerosis Risk in Communities (ARIC) Study. Operations Manual 10: Clinical Chemistry Determinations (1987), National Heart, Lung and Blood Institute, Bethesda, MD
16. Levey A.S., Eckardt K.U., Tsukamoto Y., et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67 (2005) 2089-2100
17. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
18. Coresh J., Astor B.C., McQuillan G., et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 39 (2002) 920-929
19. Manjunath G., Tighiouart H., Ibrahim H., et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 41 (2003) 47-55
20. Pereira A.C., Pereira A.B., Mota G.F., et al. NPHS2 R229Q functional variant is associated with microalbuminuria in the general population. Kidney Int 65 (2004) 1026-1030
21. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis 39 suppl 1 (2002) S1-S266
22. Thorisson G.A., Smith A.V., Krishnan L., and Stein L.D. The international HapMap project web site. Genome Res 15 (2005) 1592-1593
23. Sherry S.T., Ward M.H., Kholodov M., et al. dbSNP: The NCBI database of genetic variation. Nucleic Acids Res 29 (2001) 308-311
24. Hirschhorn J.N., Lohmueller K., Byrne E., and Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 4 (2002) 45-61
25. Gudmundsson J., Sulem P., Steinthorsdottir V., et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 39 (2007) 977-983
26. Kotowski I.K., Pertsemlidis A., Luke A., et al. A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol. Am J Hum Genet 78 (2006) 410-422
27. Caridi G., Perfumo F., and Ghiggeri G.M. NPHS2 (podocin) mutations in nephrotic syndrome. Clinical spectrum and fine mechanisms. Pediatr Res 57 (2005) 54R-61R
28. Sladek R., Rocheleau G., Rung J., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445 (2007) 881-885
29. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-678
30. Tryggvason K., Patrakka J., and Wartiovaara J. Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 354 (2006) 1387-1401